home / stock / fbio / fbio quote
Last: | $1.72 |
---|---|
Change Percent: | 0.0% |
Open: | $1.71 |
Close: | $1.72 |
High: | $1.79 |
Low: | $1.71 |
Volume: | 32,100 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.72 | $1.71 | $1.72 | $1.79 | $1.71 | 32,100 | 04-26-2024 |
$1.72 | $1.75 | $1.72 | $1.77 | $1.66 | 210,118 | 04-25-2024 |
$1.79 | $1.79 | $1.79 | $1.8 | $1.76 | 115,078 | 04-24-2024 |
$1.81 | $1.79 | $1.81 | $1.82 | $1.76 | 190,376 | 04-23-2024 |
$1.75 | $1.73 | $1.75 | $1.78 | $1.73 | 151,080 | 04-22-2024 |
$1.75 | $1.86 | $1.75 | $1.86 | $1.71 | 186,744 | 04-19-2024 |
$1.81 | $1.79 | $1.81 | $1.88 | $1.7 | 437,483 | 04-18-2024 |
$1.77 | $1.79 | $1.77 | $1.84 | $1.7624 | 245,098 | 04-17-2024 |
$1.76 | $1.76 | $1.76 | $1.81 | $1.73 | 193,443 | 04-16-2024 |
$1.82 | $1.82 | $1.82 | $1.84 | $1.72 | 336,212 | 04-15-2024 |
$1.8 | $1.83 | $1.8 | $1.87 | $1.72 | 266,269 | 04-12-2024 |
$1.82 | $1.92 | $1.82 | $1.92 | $1.77 | 202,001 | 04-11-2024 |
$1.91 | $1.89 | $1.91 | $1.93 | $1.8 | 184,452 | 04-10-2024 |
$1.89 | $1.98 | $1.89 | $1.98 | $1.85 | 181,432 | 04-09-2024 |
$1.9 | $1.84 | $1.9 | $1.9401 | $1.76 | 201,345 | 04-08-2024 |
$1.87 | $1.88 | $1.87 | $1.9 | $1.6306 | 396,312 | 04-05-2024 |
$1.87 | $1.92 | $1.87 | $1.93 | $1.85 | 196,588 | 04-04-2024 |
$1.92 | $1.94 | $1.92 | $1.94 | $1.83 | 179,481 | 04-03-2024 |
$1.93 | $1.94 | $1.93 | $1.96 | $1.79 | 203,325 | 04-02-2024 |
$1.99 | $2.05 | $1.99 | $2.053 | $1.92 | 334,925 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Fortress Biotech Inc. Company Name:
FBIO Stock Symbol:
NASDAQ Market:
Fortress Biotech Inc. Website:
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commerci...
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (...
MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced th...